Bristol-Myers Squibb Co
(NYSE:BMY)
$
55
-0.53 (-0.95%)
Market Cap: 112.31 Bil
Enterprise Value: 148.29 Bil
PE Ratio: 15.45
PB Ratio: 5.60
GF Score: 77/100 Bristol-Myers Squibb Co at TD Cowen Healthcare Conference Transcript
Mar 02, 2026 / 02:50PM GMT
Release Date Price:
$62.34
(-0.05%)
Steve Scala
Cowen and Company LLC - Analyst
Well, good morning, once again, and welcome to TD Cowen's 46th Annual Healthcare Conference. We are absolutely delighted to have Bristol-Myers Squibb here again with us this year, representing the company, Adam Lenkowsky, who is Executive Vice President and Chief Commercial Officer.
So Adam, thank you so much for being here.
Adam Lenkowsky
Bristol-Myers Squibb Co - Executive Vice President, Chief Commercialization Officer
Thanks for having me, Steve.
Questions & Answers
Steve Scala
Cowen and Company LLC - Analyst
So let's start out with a bit of a big picture. Can you remind us of any notable pushes and pulls throughout the year in terms of both revenue and OpEx we should be considering?
Adam Lenkowsky
Bristol-Myers Squibb Co - Executive Vice President, Chief Commercialization Officer
Yes, happy to do that. When I take a step back, when you think about 2025 performance, we delivered strong performance
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot